Cure My Disease

Don't miss your cure!

 Log in / Sign up

Scientists launch large registry to study rare skin cancer

NCT ID NCT07160023

Recruiting now Knowledge-focused Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study is a registry that will collect information from about 600 people with primary cutaneous T-cell lymphoma, a rare type of skin cancer. Researchers will look back at past cases and follow new ones to understand how common different forms of the disease are and how long people live with each type. No new treatments are being tested; the goal is simply to learn more about the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY CUTANEOUS T-CELL LYMPHOMAS NCT NUMBER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

primary cutaneous T-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY CUTANEOUS T-CELL LYMPHOMAS NCT NUMBER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • SC Dermatologia, Fondazione IRCCS Policlinico San Matteo

    RECRUITING

    Pavia, Pavia, 27100, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••